SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001867096-22-000042
Filing Date
2022-03-11
Accepted
2022-03-11 07:55:30
Documents
4
Effectiveness Date
2022-03-11

Document Format Files

Seq Description Document Type Size
1 S-8 xeris-formsx8.htm S-8 59551
2 EX-FILING FEES exhibit107filingfeetable.htm EX-FILING FEES 17570
3 EX-5.1 xeris-sx851opinionfinal.htm EX-5.1 5900
4 EX-23.1 a2022forms-8exhibit231final.htm EX-23.1 2296
  Complete submission text file 0001867096-22-000042.txt   86314
Mailing Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601
Business Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601 844-445-5704
Xeris Biopharma Holdings, Inc. (Filer) CIK: 0001867096 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263466 | Film No.: 22731173
SIC: 2834 Pharmaceutical Preparations